Literature DB >> 28058765

The impact of an individualized risk-adjusted approach on hypertension treatment in primary care.

Stefan Zechmann1, Oliver Senn1, Fabio Valeri1, Stefan Neuner-Jehle1, Thomas Rosemann1, Sima Djalali1.   

Abstract

Previous studies suggest that up to 60% of all patients with hypertension receive inappropriate treatment. Current 2013 European Society of Hypertension/European Society of Cardiology (ESH/ESC) guidelines recommend taking cardiovascular risk factors into account when assessing treatment for patients with hypertension. The authors hypothesize that this approach will reduce the proportion of patients receiving inappropriate treatment. In this cross-sectional study using electronic medical records of Swiss primary care patients, the authors estimate the proportion of patients receiving inappropriate treatment using two approaches: (1) based on a blood pressure threshold of 140/90 mm Hg; and (2) based on cardiovascular risk factors. A total of 22 434 patients with hypertension were identified. Based on these approaches, 72.7% and 44.6% of patients, respectively, qualified for drug treatment. In addition, 23.0% and 10.8% of patients, respectively, received inappropriate treatment. Application of the 2013 ESH/ESC guidelines reduced the proportion of patients receiving inappropriate treatment by 50%. This shows the major impact of risk adjustment and highlights the need for a patient-centered approach in hypertension treatment. ©2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  antihypertensive therapy; clinical management of high blood pressure; primary care issues; risk assessment; treatment and diagnosis/guidelines

Mesh:

Substances:

Year:  2017        PMID: 28058765      PMCID: PMC8031272          DOI: 10.1111/jch.12958

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  44 in total

1.  Study on COgnition and Prognosis in the Elderly (SCOPE).

Authors:  L Hansson; H Lithell; I Skoog; F Baro; C M Bánki; M Breteler; P U Carbonin; A Castaigne; M Correia; J P Degaute; D Elmfeldt; K Engedal; C Farsang; J Ferro; V Hachinski; A Hofman; O F James; E Krisin; M Leeman; P W de Leeuw; D Leys; A Lobo; G Nordby; B Olofsson; A Zanchetti
Journal:  Blood Press       Date:  1999       Impact factor: 2.835

2.  Routine health insurance data for scientific research: potential and limitations of the Agis Health Database.

Authors:  Hugo M Smeets; Niek J de Wit; Arno W Hoes
Journal:  J Clin Epidemiol       Date:  2011-04       Impact factor: 6.437

3.  Proportion of US adults potentially affected by the 2014 hypertension guideline.

Authors:  Ann Marie Navar-Boggan; Michael J Pencina; Ken Williams; Allan D Sniderman; Eric D Peterson
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

4.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

5.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.

Authors:  Clara K Chow; Koon K Teo; Sumathy Rangarajan; Shofiqul Islam; Rajeev Gupta; Alvaro Avezum; Ahmad Bahonar; Jephat Chifamba; Gilles Dagenais; Rafael Diaz; Khawar Kazmi; Fernando Lanas; Li Wei; Patricio Lopez-Jaramillo; Lu Fanghong; Noor Hassim Ismail; Thandi Puoane; Annika Rosengren; Andrzej Szuba; Ahmet Temizhan; Andy Wielgosz; Rita Yusuf; Afzalhussein Yusufali; Martin McKee; Lisheng Liu; Prem Mony; Salim Yusuf
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272

6.  Clinical practice and recent recommendations in hypertension management--reporting a gap in a global survey of 1259 primary care physicians in 17 countries.

Authors:  Peter Bramlage; Martin Thoenes; Wilhelm Kirch; Claude Lenfant
Journal:  Curr Med Res Opin       Date:  2007-04       Impact factor: 2.580

7.  The International Classification of Primary Care (ICPC-2): an essential tool in the EPR of the GP.

Authors:  Marc Verbeke; Diëgo Schrans; Sven Deroose; Jan De Maeseneer
Journal:  Stud Health Technol Inform       Date:  2006

8.  Prevalence of chronic medical conditions in Switzerland: exploring estimates validity by comparing complementary data sources.

Authors:  Ueli Zellweger; Matthias Bopp; Barbara M Holzer; Sima Djalali; Vladimir Kaplan
Journal:  BMC Public Health       Date:  2014-11-07       Impact factor: 3.295

9.  Trends in Prevalence, Awareness, Treatment, and Control of Blood Pressure Recorded From 2004 to 2014 During World Hypertension Day in Italy.

Authors:  Giuliano Tocci; Maria L Muiesan; Gianfranco Parati; Enrico Agabiti Rosei; Claudio Ferri; Agostino Virdis; Roberto Pontremoli; Giuseppe Mancia; Claudio Borghi; Massimo Volpe
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-10-13       Impact factor: 3.738

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  2 in total

1.  The impact of an individualized risk-adjusted approach on hypertension treatment in primary care.

Authors:  Stefan Zechmann; Oliver Senn; Fabio Valeri; Stefan Neuner-Jehle; Thomas Rosemann; Sima Djalali
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-01-06       Impact factor: 3.738

2.  Medication use and falls: Applying Beers criteria to medication review in Parkinson's disease.

Authors:  Eleanor Yusupov; Davina Chen; Bhuma Krishnamachari
Journal:  SAGE Open Med       Date:  2017-11-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.